Taiwan FDA registration f9c17a21e238c060ebb6016caddaa621
Recording of Paz G carcinoembryonic antigen-N test reagent standard
TW: 錄秘帕斯G癌胚抗原-N檢驗試劑標準液
Taiwan·Risk Class 2·Fujirebio Inc. Sagamihara Facility·Registered Mar 14, 2011 – Mar 14, 2026ExpiredRegistration details
- Analysis ID
- f9c17a21e238c060ebb6016caddaa621
- Customs Code
- DHA00602196005
Company information
- Manufacturer
- Fujirebio Inc. Sagamihara Facility
- Manufacturer Country
- Japan
- Authorized Representative
- Grand Marquis IVD CO., LTD.
Product details
- Intended Use
- Calibration reagent specially used to record Paz G carcinoembryonic antigen-N detection reagent.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 Calibrated Products
- Import Information
- import
Dates and status
- Registration Date
- Mar 14, 2011
- Expiry Date
- Mar 14, 2026
About this record
Access comprehensive regulatory information for Recording of Paz G carcinoembryonic antigen-N test reagent standard in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f9c17a21e238c060ebb6016caddaa621 and manufactured by Fujirebio Inc. Sagamihara Facility. The authorized representative in Taiwan is Grand Marquis IVD CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices